World's Best Scientists 2026 revealed!

Research.com Recognitions

  • 1981 - Robert Koch Prize

Overview

Robert M. Chanock was affiliated with the National Institutes of Health in the United States. Their career involved contributions to the scientific community recognized through awards such as the Robert Koch Prize, which was awarded in 1981.

No specific publications, co-authors, or detailed research topics have been recorded in the available data. The absence of documented recent papers and frequent publication venues suggests that a comprehensive bibliographic record is not present here.

Details regarding Robert M. Chanock's main fields of study, subfields, and primary research topics are also not captured in the current dataset. Similarly, there are no records of book publications linked to this scientist in the provided information.

This profile is based solely on the data available and reflects an overview of Robert M. Chanock's professional identification and recognition through the award. The scientist is noted to be deceased, and the presentation follows a past-tense description accordingly.

Best Publications

  • GROWTH ON ARTIFICIAL MEDIUM OF AN AGENT ASSOCIATED WITH ATYPICAL PNEUMONIA AND ITS IDENTIFICATION AS A PPLO

    R. M. Chanock;L. Hayflick;M. F. Barile

  • A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

    Dennis R. Burton;Carlos F. Barbas;Mats A. A. Persson;Scott Koenig

  • EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN WASHINGTON, D.C.I. IMPORTANCE OF THE VIRUS IN DIFFERENT RESPIRATORY TRACT DISEASE SYNDROMES AND TEMPORAL DISTRIBUTION OF INFECTION

    Hyun Wha Kim;Julita O. Arrobio;Carl D. Brandt;Barbara C. Jeffries

  • Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development

    Peter L. Collins;Myron G. Hill;Ena Camargo;Haim Grosfeld

  • Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.

    Kenneth McIntosh;Jane H. Dees;Walter B. Becker;Albert Z. Kapikian

  • Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

    Yasutaka Hoshino;Mitzi M. Sereno;Karen Midthun;Jorge Flores

  • Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

    Robert A. Olmsted;Narayanasamy Elango;Gregory A. Prince;Brian R. Murphy

  • Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in Man

    Brian R. Murphy;Julius A. Kasel;Robert M. Chanock

  • ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN REOVIRUS-LIKE AGENT OF INFANTILE GASTROENTERITIS

    Robert H. Yolken;Hyun Wha Kim;Thomas Clem;Richard G. Wyatt

  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  • A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.

    Harold S. Ginsberg;Lyle L. Moldawer;Pravinkumar B. Sehgal;Miriam Redington

  • INFECTIONS IN 18, 000 INFANTS AND CHILDREN IN A CONTROLLED STUDY OF RESPIRATORY TRACT DISEASE. I. ADENOVIRUS PATHOGENICITY IN RELATION TO SEROLOGIC TYPE AND ILLNESS SYNDROME

    Carl D. Brandt;Hyun Wha Kim;Andrew J. Vargosko;Barbara C. Jeffries

  • Role of early region 3 (E3) in pathogenesis of adenovirus disease.

    Harold S. Ginsberg;Ulla Lundholm-Beauchamp;Robert L. Horswood;Benvenuto Pernis

  • A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production.

    D. Taylor-Robinson;R. H. Purcell;D. C. Wong;R. M. Chanock

  • Protective effect of antibody to parainfluenza type 1 virus.

    C B Smith;R H Purcell;J A Bellanti;R M Chanock

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens

    Anthony R. Kalica;Harry B. Greenberg;Richard G. Wyatt;Jorge Flores

  • Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis.

    Raphael Dolin;Raphael Dolin;Neil R. Blacklow;Neil R. Blacklow;Herbert L Dupont;Herbert L Dupont;Robert F. Buscho;Robert F. Buscho

  • Human rotavirus type 2: cultivation in vitro

    Richard G. Wyatt;Walter D. James;Edward H. Bohl;Kenneth W. Theil

  • Reoviruslike Agent in Stools: Association with Infantile Diarrhea and Development of Serologic Tests

    Albert Z. Kapikian;Hyun Wha Kim;Richard G. Wyatt;William J. Rodriguez

  • A mouse model for investigating the molecular pathogenesis of

    Harold S. Ginsberg;L Lyle;Pravinkumar B. SEHGALt;Miriam Redington

Frequent Co-Authors

Albert Z. Kapikian
Albert Z. Kapikian National Institutes of Health
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Karl M. Johnson
Karl M. Johnson Centers for Disease Control and Prevention
Robert H. Purcell
Robert H. Purcell National Institute of Allergy and Infectious Diseases
Harry B. Greenberg
Harry B. Greenberg Stanford University
Yasutaka Hoshino
Yasutaka Hoshino National Institutes of Health
William T. London
William T. London National Institutes of Health
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Gregory A. Prince
Gregory A. Prince National Institutes of Health
Peter L. Collins
Peter L. Collins National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens various career pathways, many of which can be complemented by online degrees. For those seeking flexible learning options, exploring programs that suit diverse backgrounds is essential. For example, if you face challenges like a criminal record, consider the best degree for felons that provide second chances and promising career prospects.

Microbiology graduates might also explore the healthcare sector. Pursuing qualifications like becoming a functional medicine nurse practitioner combines biological understanding with patient care, offering rewarding career growth.

Alternatively, roles in health information and administrative fields are growing rapidly. Careers such as medical coding offer competitive salaries, so investigating opportunities like the certified professional coder salary and certification pathways can be valuable.

Additionally, a health information management bachelor degree salary reflects the promising future for those managing healthcare data—a field increasingly essential as medical technology advances.

Best Scientists Citing Robert M. Chanock

Recently Published Articles